Denali Advisors LLC Vanda Pharmaceuticals Inc. Transaction History

Denali Advisors LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Jan 21, 2022	SELL	$15.69 - $21.14 $1.4 Million - $1.89 Million	-89,300 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$15.35 - $21.27 $1.37 Million - $1.9 Million	89,300 New	89,300 $1.53 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $260M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.